At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optimizing Vancomycin Therapy in Children
In Brief
An observational study for Sepsis and 3 related conditions. Completed, enrolled 29 participants across 1 site.
Detailed Summary
The purpose of Opt Vanc is to evaluate the feasibility of Bayesian dose adaptation, based on a previously-developed population pharmacokinetic (PK) model and a single optimally timed PK sample, to predict vancomycin area under the curve (AUC) in critically ill children.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis, Critical Illness, Infections, Drug Toxicity
CountriesUnited States
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartDec 2022
First PostedJan 2023
Primary CompletionNov 2023
TodayJul 2026
First PostedJan 20, 2023
Enrollment StartDec 12, 2022
Primary CompletionNov 22, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.4 years ago